Vendor Intelligence Report: LN Peptides

Published 3 Jul 2026. 26-page investigative report on who is behind LN Peptides: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Across 36 Finnrick lab tests, LN Peptides records 27 pass / 9 fail for a 75% overall pass rate: retatrutide and tirzepatide are the stronger reads, while tesamorelin is materially weak. The full…